EP2086543A2 — Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
Assigned to University of Missouri Columbia · Expires 2009-08-12 · 17y expired
What this patent protects
The present disclosure relates to pharmaceutical compositions comprising combinations of proton pump inhibitors, their salt forms or related compounds and at least one other pharmaceutically active agent. Methods of using such compositions, including methods of and an apparatus f…
USPTO Abstract
The present disclosure relates to pharmaceutical compositions comprising combinations of proton pump inhibitors, their salt forms or related compounds and at least one other pharmaceutically active agent. Methods of using such compositions, including methods of and an apparatus for administering such com ounds, are also rovided.
Drugs covered by this patent
- Dexilant (DEXLANSOPRAZOLE) · Takeda
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.